Incyte

1801 Augustine Cut-Off, Wilmington, DE 19803

Public
Healthcare & Pharmaceuticals - Biotechnology
around $100 - 500M
around 1K - 5K
(302) 498-6700
(302) 636-5454


Incyte Corporation (Incyte) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs. Its advanced compound, JAKAFI (ruxolitinib), also known as INCB18424 and INC424, is an oral Janus associated kinase (JAK) inhibitor used for the treatment for patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF. The Company has a second oral JAK1 and JAK2 inhibitor, LY3009104 (INCB28050), which is subject to a collaboration agreement with Eli Lilly and Company in which Lilly received worldwide development and commercialization rights for the compound for inflammatory and autoimmune diseases. In November 2011, JAKAFI bec... (Source: SEC reports)


Competitor - 1/9
Which company is more competitive with Incyte?


231 Contacts at this company
Katie McGinn
Associate Director
Keith Folsom
Senior Director, US Business Information ...
Rodrigo Hess Michelini
Principal Investigator
Scot Hughes
Senior Director, Chemical and Process ...
Ken Kumar
Executive Director
Carol Reese
eClinical Manager Clinical Trial Management
Lauren Kwiecinski
Senior Director, Investor Relations ...
Yun-Long Li, Ph.D.
Sr. Director, Chemistry
Holly Koblish
Senior Director, Pharmacology

Sep 13, 2018 17:30:37
WILMINGTON, Del.--(BUSINESS WIRE)--Today on MPN Awareness Day and throughout September, Blood Cancer Awareness Month, Incyte Corporation [...]

Sep 13, 2018 17:30:33
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced positive results from its randomized, dose-ranging, vehicle- and active-controlled [...]

Sep 13, 2018 17:06:17
WILMINGTON, Del.--(BUSINESS WIRE)--Today on MPN Awareness Day and throughout September, Blood Cancer Awareness Month, Incyte Corporation [...]

Sep 11, 2018 17:30:44
WILMINGTON, Del. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Incyte Corporation (NASDAQ:INCY) and Foundation Medicine, Inc., today announced that the [...]

Sep 11, 2018 17:06:27
WILMINGTON, Del. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Incyte Corporation (NASDAQ:INCY) and Foundation Medicine, Inc., today announced that the [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.